USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO

Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaci...

Full description

Saved in:
Bibliographic Details
Main Authors CHU, ZHI-LIANG, JONES, ROBERT M, LEONARD, JAMES N, LEHMANN, JUERG
Format Patent
LanguageBosnian
English
Published 10.10.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaciji sa inhibitorom dipepti dil pepti daze IV (DPP-IV) za liječenje i prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Agonist GPR119 receptora i inhibitora DPP-IV sti mulišu formiranje kosti kod jedinki. The present invention relates to the use of GPR119 receptor agonists for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. The present invention further relates to the use of a GPR119 receptor agonist in combination with a dipeptidyl peptidase IV (DPP-IV) inhibitor for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. A GPR119 receptor agonist and the combination of a GPR119 receptor agonist and a DPP-IV inhibitor promote bone formation in an individual.
AbstractList Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Predstavljeni pronalazak se dalje odnosi na primjenu agonista GPR119 receptora u konbinaciji sa inhibitorom dipepti dil pepti daze IV (DPP-IV) za liječenje i prevenciju stanja koje karakteriše niska koštana masa, kao što je osteoporoza, i za povećanje koštane mase kod jedinki. Agonist GPR119 receptora i inhibitora DPP-IV sti mulišu formiranje kosti kod jedinki. The present invention relates to the use of GPR119 receptor agonists for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. The present invention further relates to the use of a GPR119 receptor agonist in combination with a dipeptidyl peptidase IV (DPP-IV) inhibitor for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. A GPR119 receptor agonist and the combination of a GPR119 receptor agonist and a DPP-IV inhibitor promote bone formation in an individual.
Author CHU, ZHI-LIANG
LEHMANN, JUERG
JONES, ROBERT M
LEONARD, JAMES N
Author_xml – fullname: CHU, ZHI-LIANG
– fullname: JONES, ROBERT M
– fullname: LEONARD, JAMES N
– fullname: LEHMANN, JUERG
BookMark eNqFzU0KwjAQBeAsdOHfFWQOoGBVUJdpnLYBmwmZuHBVisSVtIV6AI9uW927Gt77HsxUjKq6ChPxvjICJZBaF0UncKjQenIgUzKaPUPSBW2UQ8napBCTQcglM0hzHtB35Hsi9kiWHLHm1cCK8libTsmAz9BJe-s-XL7zvkBPczF-lM82LH53JpYJepWtQ1MXoW3Ke6jCq8jRbg_7zVHu_g4-YHg80A
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate AGONISTI GPR119 RECEPTORA U POSTUPCIMA ZA POVEĆANJE KOŠTANE MASE I ZA LIJEČENJE OSEOPOROZE, KAO I DRUGIH STANJA KOJA KARAKTERIŠE NISKA KOŠTANA MASA I SA NJIMA POVEZANA KOMBINOVANA TERAPIJA.
ExternalDocumentID MEP27408A
GroupedDBID EVB
ID FETCH-epo_espacenet_MEP27408A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Bosnian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MEP27408A3
Notes Application Number: ME2008P000274
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101010&DB=EPODOC&CC=ME&NR=P27408A
ParticipantIDs epo_espacenet_MEP27408A
PublicationCentury 2000
PublicationDate 20101010
PublicationDateYYYYMMDD 2010-10-10
PublicationDate_xml – month: 10
  year: 2010
  text: 20101010
  day: 10
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies ARENA PHARMACEUTICALS, INC
RelatedCompanies_xml – name: ARENA PHARMACEUTICALS, INC
Score 2.790367
Snippet Predstavljeni pronalazak se odnosi na primjenu agonista GRP119 receptora za liječenje ili prevenciju stanja koje karakteriše niska koštana masa, kao što je...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101010&DB=EPODOC&locale=&CC=ME&NR=P27408A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8MgFCdzGvWm8_tj4WB6srG4busOjWkp3WrS0hRm5smMlhkv2-JqvPqnS7FTLwscCD9C8kjegx_w3gPgJncKYcuB4iYISdMunJ45lTI3pUS92RTNlN2srgbipDca24-T7qQBXte-MDpO6KcOjqg0Klf6Xmp7vfy7xAr038rVnXhTXYuHkLuBUbNjpIsR-C5JaUCxgbEbEyPJ3FSxL8vxtsC2OkP3q79f5MmvXFKW__eT8ADspGqqeXkIGmLVAnt4nXatBXbj-rVbNWvFWx2BrzEjkIZwmGYIDWBGMEk5zaA3pEnEOIOKzEFF0DPisSgZQp8mBMYeY9BLAg1yBfEKoowTmtKMsojdahjT2I9-wuJCPiKZlz7DKpWGHl51EE6PQTskHI9MJcrL76K9xKQWuXMCmvPFXJ4BKB2nO5DFTCAk7MqFdNrp5_a91bUKJBxLnIPTDZNcbEQuwb5-UNf1CjTL9w95rfbpUrT1Gn8DuxaPFg
link.rule.ids 230,309,783,888,25578,76886
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8MgFCdzGudN5_cnB9OTjcV1szs0ph90ra6lKczM0zJaZrxsi5vx6p8uxU69LHAg70dIIHnv8QPeA4Dr3Cq4KbqSmyAkdLOwOvpYiFwXAnUmYzSRdrM8GoiTTjgwH4ftYQ28rmJhVJ7QT5UcUWpULvV9qez1_O8Qy1dvKxe3_E2KZg8Bs32tYsdIFc13bZwSn3ia59kx1pLMTiX7MixnA2zK_bVVqgJ-dsuQlPl_fxLsgq1UDjVd7oEaXzRBw1t9u9YE23F12y2bleIt9sHXgGJIAthLM4S6MMMeThnJoNMjSUQZhZLMQUnQM-zQKOlBlyQYxg6l0El8BTIJsRIilGGSkozQiN4o2COxG_2kxYUsxJmTvsDyKw3VvRRgRg7AZYCZF-pyKqPfRRvFuJpy6xDUp7OpOAZQWFa7K4oJR4ibZQjpuHWfm3dG2ygQtwx-Ao7WDHK6FrkCjZDF_VE_Sp7OwI66XFf1HNSX7x_iQvrsJb9U6_0NnaeSCA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+GPR119+RECEPTOR+AGONISTS+FOR+INCREASING+BONE+MASS+AND+FOR+TREATING+OSTEOPOROSIS%2C+AND+COMBINATION+THERAPY+RELATING+THERETO&rft.inventor=CHU%2C+ZHI-LIANG&rft.inventor=JONES%2C+ROBERT+M&rft.inventor=LEONARD%2C+JAMES+N&rft.inventor=LEHMANN%2C+JUERG&rft.date=2010-10-10&rft.externalDBID=A&rft.externalDocID=MEP27408A